moxisylyte has been researched along with Impotence, Arteriogenic in 2 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Porst, H | 1 |
| Buvat, J | 1 |
| Lemaire, A | 1 |
| Herbaut-Buvat, M | 1 |
2 other studies available for moxisylyte and Impotence, Arteriogenic
| Article | Year |
|---|---|
The rationale for prostaglandin E1 (alpha-alprostadil) in the management of male impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Male; Molsidomine; Moxisylyte; P | 1995 |
Intracavernous pharmacotherapy: comparison of Moxisylyte and prostaglandin E1.
Topics: Adult; Aged; Alprostadil; Dose-Response Relationship, Drug; Erectile Dysfunction; Fibrosis; Humans; | 1996 |